Phase 2 Peripheral T Cell Lymphoma Clinical Trials
25 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 25 trials
Recruiting
Phase 2
Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
Relapsed/Refractory Peripheral T Cell Lymphoma
The First Affiliated Hospital of Soochow University31 enrolled1 locationNCT05182957
Recruiting
Phase 2
Study of Lacutamab in Peripheral T-cell Lymphoma
Relapse/RecurrencePeripheral T Cell Lymphoma
The Lymphoma Academic Research Organisation56 enrolled64 locationsNCT04984837
Recruiting
Phase 2
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
T-cell LymphomaT-cell Prolymphocytic LeukemiaLymphoma, T-Cell+5 more
Jonathan Brammer44 enrolled1 locationNCT07356245
Recruiting
Phase 1Phase 2
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
Peripheral T Cell LymphomaT-lymphoblastic LymphomaRelapsed/Refractory B-cell Acute Lymphoblastic Leukemia+4 more
Beijing Biotech96 enrolled1 locationNCT07523555
Recruiting
Phase 2
Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma
Peripheral T Cell Lymphoma
Fudan University51 enrolled1 locationNCT04512534
Recruiting
Phase 2
Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
Relapsed/Refractory Peripheral T Cell Lymphoma
Fudan University25 enrolled1 locationNCT06519526
Recruiting
Phase 2
A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study
Peripheral T Cell Lymphoma
M.D. Anderson Cancer Center30 enrolled1 locationNCT06630091
Recruiting
Phase 2Phase 3
A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine40 enrolled1 locationNCT07389616
Recruiting
Phase 1Phase 2
Evaluate the Safety and Clinical Activity of HH2853
Advanced Solid TumorPeripheral T Cell LymphomaFL Lymphoma+1 more
Haihe Biopharma Co., Ltd.254 enrolled25 locationsNCT04390737
Recruiting
Phase 1Phase 2
Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
Sun Yat-sen University101 enrolled1 locationNCT07093710
Recruiting
Phase 1Phase 2
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Acute Myeloid LeukemiaNon-Hodgkin LymphomaMultiple Myeloma+3 more
CellCentric Ltd.250 enrolled39 locationsNCT04068597
Recruiting
Phase 2
Amping up With PemJAK
Non-Hodgkin LymphomaPeripheral T Cell LymphomaPrimary Mediastinal B Cell Lymphoma+5 more
Seda S. Tolu53 enrolled1 locationNCT07283822
Recruiting
Phase 1Phase 2
Linperlisib Combined With Chidamide in Patients With PTCL
Peripheral T Cell Lymphoma
Yanyan Liu134 enrolled6 locationsNCT06421948
Recruiting
Phase 2
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Peripheral T Cell Lymphoma
UNC Lineberger Comprehensive Cancer Center20 enrolled2 locationsNCT04083495
Recruiting
Phase 2
GVM±R in Patients With Relapsed or Refractory Aggressive NHL.
Diffuse Large B Cell LymphomaPeripheral T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China115 enrolled1 locationNCT06244368
Recruiting
Phase 2
Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma
Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaRefractory T-Cell Lymphoma
The First Affiliated Hospital of Xiamen University33 enrolled1 locationNCT06151106
Recruiting
Phase 2
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma
Peripheral T Cell LymphomaEpigenetic Repression
Institute of Hematology & Blood Diseases Hospital, China37 enrolled1 locationNCT05958719
Recruiting
Phase 1Phase 2
Golidocitinib Plus CHOP in Newly Diagnosed PTCL
Peripheral T Cell Lymphoma
Peking Union Medical College Hospital68 enrolled1 locationNCT06739265
Recruiting
Phase 2
RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.
Peripheral T Cell Lymphoma
Xianmin Song, MD50 enrolled1 locationNCT06468267
Recruiting
Phase 2
CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
Peripheral T Cell Lymphoma
Tianjin Medical University Cancer Institute and Hospital115 enrolled1 locationNCT06433362